Searching. Please wait…
1583
37
170
29013
4402
2599
347
386
Abstract: Non-alcoholic fatty liver disease (NAFLD) is becoming a major cause of liver disease-related morbidity, as well as mortality. Importantly, NAFLD is considered a mediator of systemic diseases including cardiovascular disease. Its prevalence is expected to increase, mainly due to its close association with obesity and type 2 diabetes mellitus (T2D). In addition, T2D and NAFLD share common pathophysiological mechanisms, and one can lead to or worsen the other. Therefore, a close collaboration between primary care physician, endocrinologists and hepatologists is essential to optimize the management of patients with NAFLD and T2D. Here, we summarize relevant aspects about NAFLD and T2D that all clinician managing these patients should know as well as current therapeutic options for the treatment of T2D associated with NAFLD.
Fuente: Gastroenterología y Hepatología, 2023, 46, 815-825
Publisher: Elsevier
Year of publication: 2023
No. of pages: 11
Publication type: Article
DOI: 10.1016/j.gastrohep.2022.12.002
ISSN: 0210-5705
Publication Url: https://doi.org/10.1016/j.gastrohep.2022.12.002
Read publication
GENUA, IDOIA
PAULA IRUZUBIETA COZ
JUAN CARLOS RODRÍGUEZ DUQUE
PÉREZ, ANTONIO
JAVIER CRESPO GARCIA
Back